期刊文献+

Fabry病一例

下载PDF
导出
摘要 1临床资料 患者男,21岁。因间断发热、血压升高伴肢端疼痛9年余就诊。患者自2003年7月起,无明显诱因下出现发热,体温波动于37.0~38.0℃,可自行消退,伴双手、双下肢远端指(趾)间关节发作性发白、变凉和较剧烈疼痛,当时血压为190/100mmHg(1mmHg=0.133kPa)。其后每天早晨约5点左右出现发热、肢端疼痛伴血压升高。疼痛会因气温改变、运动等诱因加剧发作,每次持续时间为20min至数小时,能自行缓解。
出处 《上海医学》 CAS CSCD 北大核心 2012年第9期818-820,I0003,共4页 Shanghai Medical Journal
  • 相关文献

参考文献8

  • 1GERMAIN D P, Fabry disease[J]. Orphanet J Rare Dis, 2010, 22(5): 30.
  • 2LV Y L, WANG W M, PAN X X, et al. A successful screening for Fabry disease in a Chinese dialysis patient population[J]. Clin Genet, 2009, 76(2): 219-221.
  • 3MONSERRAT L, GIMENO-BLANES J R, MARIN F, et al. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy[J]. J Am Coll Cardiol, 2007, 50(25): 2399-2403.
  • 4陈佳韵,王朝晖,潘晓霞,王伟铭,任红,陈晓农,巫永睿,陆颖,陈楠.Fabry病家系的α-半乳糖苷酶A基因突变研究[J].中华肾脏病杂志,2005,21(11):654-658. 被引量:14
  • 5MACDERMOT K D, HOLMES A, MINERS A H. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males[J]. J Med Genet, 2001, 38(11): 750-760.
  • 6DESNICK R J, IOANNOU Y A, ENG C M. Alpha galactosidase A deficiency: Fabry disease. // Scriver CR, Beaudet AL, Sly WS, eds. The metabolic and molecular bases of inherited disease[M]. 8th ed. New York: McGraw- Hill, 2001: 3733-3774.
  • 7HUGHES D A, MALMEN.S M, DEEGAN P B, et al. Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease[J]. J Med Genet, 2012, 49 (3) : 212-220.
  • 8FARAGGIANA T, CHURG J, GRISHMAN E, et al. Light-and electron-microscopic histochemistry of Fabry' s disease[J]. Am J Pathol, 1981, 103(2): 247-26Z.

二级参考文献15

  • 1Desnick RJ. Alpha galactosidase A deficiency: Fabry disease.In: Scriver CR, Beaudet AL, Sly WS, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York:McGraw-Hill, 2001. 3733-3774.
  • 2Brady RO, Schiffmann R. Clinical features and recent advances in therapy for Fabry disease. JAMA, 2000, 284:2771-2775.
  • 3Stenson PD, Ball EV, Mort M. Human Gene Mutation Database (HGMD). 2003 update. Hum Mutat, 2003, 21:577-581.
  • 4Tse KC, Chen KW, Tin VP. Clinical features and genetic analysis of a Chinese kindred with Fabry's disease. Nephrol Dial Transplant, 2003, 18: 182-186.
  • 5Meikle PJ, Hopwood J J, Clague AE. Prevalence of lysosomal storage disorders. JAMA, 1999, 281:249-54.
  • 6Mehta A, Ricci R, Widmer U, et al. Fabry disease defined:baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest, 2004, 34: 236-242.
  • 7MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Md Genet, 2001, 38:769-807.
  • 8Kornreich R, Desnick RJ, Bishop DE. Nucleotide sequence of the human alpha-galactosidase A gene. Nucleic Acids Res,1989, 17: 3301-330.
  • 9Matsuzawa F, Aikawa S, Doi H, et al. Fabry disease:correlation between structural changes in alpha-galactosidase,and clinical and biochemical phenotypes. Hum Genet, 2005,117: 317-38.
  • 10Garman SC, Garboczi DN. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol, 2004, 337: 319-335.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部